NSE India LimitedUnlisted Shares
₹ 2,035▼2.86%(60.00)
About the company
The National Stock Exchange of India Limited (NSE) is one of India's leading stock exchanges and a key part of the country's financial market infrastructure. Incorporated in 1992, NSE was recognized as a stock exchange by SEBI in 1993 and commenced operations in 1994, starting with the wholesale debt market and later expanding into the cash market segment.
NSE played an important role in modernizing India's capital markets by introducing fully automated, electronic screen-based trading. Over the years, it expanded its offerings across various segments, including equities, derivatives, debt, and other financial products, making trading more accessible and technology-driven for market participants.
The company operates an integrated business model that includes trading and listing services, clearing and settlement, indices, market data, technology solutions, and financial education. Its strong focus on technology and innovation has helped NSE build a reliable and scalable trading infrastructure that serves investors and market participants across India.
As one of the country's major financial market institutions, NSE continues to attract interest from investors in the unlisted market. Investors considering NSE unlisted shares should understand the company's business, financial performance, valuation, and the prevailing NSE unlisted share price before making an investment decision. Since unlisted shares may have limited liquidity and carry market-related risks, proper research and due diligence are important before investing.
Fundamentals
Valuation
- 52 week high
- ₹2,225
- 52 week low
- ₹1,875
- P/B ratio
- 16.07
- Debt to equity
- 0
- ROE (%)
- 31.7%
- Book value
- ₹129.76
- Face value
- ₹1
- Valuation
- —
Registry
- ISIN number
- INE721I01024
Figures in cr ·
Financials
| P&L Statement | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Revenue | 11856 | 14780 | 17141 | 16601 |
| EBITDA | 9631 | 11611 | 12881 | 11225 |
| OPM | 81.23 | 78.56 | 75.15 | 67.62 |
| PBT | 10041 | 11184 | 16057 | 13896 |
| PAT | 7501 | 8406 | 12188 | 10180 |
| EPS | 151.54 | 169.82 | 49.24 | 41.13 |
Shareholding Pattern
Leadership
Frequently asked questions
Common questions on NSE India Limited Unlisted Shares—tap a row to read the answer.
Q.1What is the lock-in period for NSE India Limited Unlisted Shares?
NSE shares held in the unlisted market can generally be bought or sold before a public listing, subject to availability and any applicable transfer restrictions. However, if NSE comes out with an IPO, shares acquired before the IPO may be subject to a lock-in period after listing as per the SEBI regulations applicable at that time.
The exact lock-in period may depend on the type of shareholder and the regulations in force when the company lists. Investors should check the latest rules before investing, especially if they are planning to sell their shares soon after a potential IPO.
Q.2What is the process for buying NSE Unlisted Shares?
If you want to buy NSE unlisted shares, you generally need an active Demat account, PAN, bank account, and completed KYC. The first step is to check the current price and availability of shares in the unlisted market.
Once you decide on the quantity and agree to the transaction terms, you can complete the payment. After the transaction is processed, the shares are transferred to your Demat account as per the agreed settlement process.
Before investing, take time to understand the company's financial performance, valuation, and the risks involved in unlisted investments.
Q.3How long does it take to complete the purchase of NSE Unlisted Shares?
The time required to complete a purchase depends on factors such as share availability, KYC verification, payment confirmation, and the settlement process.
Once all the required details are verified and the transaction is confirmed, the shares are transferred to the buyer's Demat account within the agreed timeline. It is always a good idea to confirm the expected settlement time before making the payment and check your Demat account once the transfer is completed.
Q.4What are the costs involved in buying NSE Unlisted Shares?
The main cost of purchasing shares is based on the price per share and the quantity you decide to buy. Depending on the transaction, there may also be additional charges, taxes, or other applicable fees.
Before completing the purchase, ask for a clear breakdown of the total amount payable. This will help you understand the actual cost of your investment and avoid any confusion about additional charges later.
Q.5What documents are required for buying NSE Unlisted Shares?
The documentation process is generally straightforward. Investors usually need a PAN card, valid identity proof, an active Demat account, Client Master Report (CMR), bank account details, and completed KYC.
Additional documents may be required depending on the nature of the transaction or applicable compliance requirements. Make sure the details you provide match your Demat account information so that the shares can be transferred without unnecessary delays.
Q.6How is the price of NSE Unlisted Shares determined?
The NSE unlisted share price is mainly influenced by demand and supply in the private market. Factors such as the company's financial performance, valuation, business growth, investor interest, share availability, and developments related to a potential IPO can also affect the price.
Since NSE's own shares are not publicly traded on a stock exchange, there is no continuously changing live market price like there is for listed companies. This means the quoted price can vary between transactions and may change over time.
Investors should look beyond just the current price and consider the company's overall financial position and valuation before making an investment decision.
Trending shares
High-demand unlisted opportunities currently available for trade.
From the blog
Notes on unlisted markets, execution hygiene, and how we think about risk—no hype, no ticker spam.

APTUS PHARMA IPO
Aptus Pharma Limited rolled out its 100% book-built BSE SME public offering worth ₹13.02 Crore. Review crucial parameters for retail investors, featuring the ₹65–₹70 price band, working capital allocations, and an evaluation of its contract-manufacturing partner model.

NEPHROPLUS (NEPHROCARE HEALTH SERVICES) IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

APOLLO TECHNO INDUSTRIES IPO
Apollo Techno Industries Limited has announced its public offering details. Explore the essential investment parameters for retail and institutional bidders, highlighting the fixed price band, lot structure, key market deadlines, and an overview of its industrial manufacturing footprint.

NEOCHEM BIO IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

ANONDITA MEDICARE IPO
Anondita Medicare Limited rolled out its 100% book-built SME public offering worth ₹69.50 Crore on the NSE SME platform. Dig into the critical parameters for investors, highlighting the ₹137–₹145 price band, key working capital objectives, and an analysis of its flagship brand 'COBRA' within the growing sexual wellness market.

NEPTUNE LOGITEK IPO
Explore the Neptune Logitek IPO, including issue details, business strengths, risks, and investment analysis.
